BioXcel Therapeutics
-$0.49 (-1.48%) Today
$0.00 (0.00%) As of 9:14 PM UTC after-hours
Why Robinhood?
You can buy or sell BTAI and other stocks, options, and ETFs commission-free!
About BTAI
BioXcel Therapeutics, Inc. Common Stock, also called BioXcel Therapeutics, is a clinical stage biopharmaceutical company, which focuses on drug development.
CEO
Vimal D. Mehta
Employees
50
Headquarters
New Haven, Connecticut
Founded
2017
BTAI Key Statistics
Market Cap
803.93M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
372.96K
High Today
$33.86
Low Today
$32.32
Open Price
$32.53
Volume
419.75K
52 Week High
$71.50
52 Week Low
$28.00
Analyst Ratings
100%
of 9 ratings
Buy
100%
Hold
0%
Sell
0%
BTAI Earnings
-$1.08
-$0.87
-$0.66
-$0.45
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.94 per share
Actual
-$1.08 per share